Ellis Investment Partners’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-111
| Closed | -$15K | – | 248 |
|
|
2022
Q3 | $15K | Sell |
111
-240
| -68% | -$32.4K | ﹤0.01% | 516 |
|
|
2022
Q2 | $51K | Hold |
351
| – | – | 0.01% | 403 |
|
|
2022
Q1 | $56K | Hold |
351
| – | – | 0.01% | 403 |
|
|
2021
Q4 | $66K | Hold |
351
| – | – | 0.02% | 383 |
|
|
2021
Q3 | $70K | Hold |
351
| – | – | 0.02% | 358 |
|
|
2021
Q2 | $70K | Hold |
351
| – | – | 0.02% | 356 |
|
|
2021
Q1 | $62K | Hold |
351
| – | – | 0.02% | 356 |
|
|
2020
Q4 | $60K | Sell |
351
-8
| -2% | -$1.37K | 0.02% | 351 |
|
|
2020
Q3 | $58K | Hold |
359
| – | – | 0.02% | 344 |
|
|
2020
Q2 | $59K | Hold |
359
| – | – | 0.02% | 329 |
|
|
2020
Q1 | $44K | Hold |
359
| – | – | 0.02% | 319 |
|
|
2019
Q4 | $50K | Hold |
359
| – | – | 0.02% | 339 |
|
|
2019
Q3 | $41K | Hold |
359
| – | – | 0.01% | 363 |
|
|
2019
Q2 | $46K | Buy |
+359
| New | +$46K | 0.02% | 336 |
|